Position in NAMS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,451,433
+$1,565,525 QoQ
Shares Held
72,335
+161.4% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#91
of 198 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Headlands Technologies LLC holds $60,689,199 across 67 Biotechnology names. NAMS ranks #5 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,545 | $6,575,229 | |
| 2 | RPRX |
Royalty Pharma plc
|
90,729 | $5,087,175 | |
| 3 | INSM |
INSMED Inc
|
40,855 | $4,355,960 | |
| 4 | BNTX |
BioNTech SE
|
27,087 | $2,520,445 | |
| 5 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
72,335 | $2,451,433 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
248,550 | $2,176,055 | |
| 7 | ABCL |
AbCellera Biologics Inc.
|
246,252 | $1,933,078 | |
| 8 | NVAX |
Novavax Inc
|
190,547 | $1,794,952 |
All Filings in NAMS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,451,433 | 72,335 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $885,908 | 27,676 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||